Tangui Maurice

13.7k total citations · 1 hit paper
206 papers, 11.6k citations indexed

About

Tangui Maurice is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Tangui Maurice has authored 206 papers receiving a total of 11.6k indexed citations (citations by other indexed papers that have themselves been cited), including 138 papers in Molecular Biology, 99 papers in Cellular and Molecular Neuroscience and 43 papers in Pharmacology. Recurrent topics in Tangui Maurice's work include Pharmacological Receptor Mechanisms and Effects (95 papers), Receptor Mechanisms and Signaling (71 papers) and Neuroscience and Neuropharmacology Research (57 papers). Tangui Maurice is often cited by papers focused on Pharmacological Receptor Mechanisms and Effects (95 papers), Receptor Mechanisms and Signaling (71 papers) and Neuroscience and Neuropharmacology Research (57 papers). Tangui Maurice collaborates with scholars based in France, United States and Germany. Tangui Maurice's co-authors include Alain Privat, Tsung‐Ping Su, Johann Meunier, Brian Lockhart, Tsung-Ping Su, Pascal Romieu, Alexandre Urani, Vân‐Ly Phan, Laurent Givalois and Toshitaka Nabeshima and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and Journal of Neuroscience.

In The Last Decade

Tangui Maurice

204 papers receiving 11.4k citations

Hit Papers

The pharmacology of sigma-1 receptors 2009 2026 2014 2020 2009 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tangui Maurice France 58 7.0k 4.7k 2.0k 1.9k 1.3k 206 11.6k
Jos Prickaerts Netherlands 62 5.1k 0.7× 3.7k 0.8× 1.7k 0.9× 2.8k 1.4× 1.1k 0.8× 239 11.7k
Frank P. Bymaster United States 57 5.0k 0.7× 6.6k 1.4× 1.4k 0.7× 3.1k 1.6× 879 0.7× 141 12.7k
Chris G. Parsons Germany 45 3.6k 0.5× 5.7k 1.2× 2.5k 1.3× 1.9k 1.0× 746 0.6× 146 9.3k
John Atack United Kingdom 57 4.2k 0.6× 5.2k 1.1× 1.5k 0.7× 1.4k 0.7× 438 0.3× 189 10.2k
Guy A. Higgins Canada 60 3.8k 0.5× 5.9k 1.2× 1.6k 0.8× 1.2k 0.6× 393 0.3× 153 9.1k
Gary L. Wenk United States 57 2.9k 0.4× 4.0k 0.8× 2.1k 1.1× 2.1k 1.1× 668 0.5× 159 9.0k
Tsung‐Ping Su United States 56 8.9k 1.3× 5.2k 1.1× 846 0.4× 1.1k 0.6× 1.4k 1.1× 132 11.4k
Giancarlo Pepeu Italy 58 3.9k 0.6× 5.4k 1.2× 2.0k 1.0× 3.0k 1.5× 338 0.3× 245 10.4k
Steven Mennerick United States 54 4.5k 0.6× 6.1k 1.3× 2.0k 1.0× 692 0.4× 643 0.5× 187 10.3k
Rudi D’Hooge Belgium 52 3.9k 0.6× 2.5k 0.5× 3.7k 1.9× 914 0.5× 446 0.3× 184 9.8k

Countries citing papers authored by Tangui Maurice

Since Specialization
Citations

This map shows the geographic impact of Tangui Maurice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tangui Maurice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tangui Maurice more than expected).

Fields of papers citing papers by Tangui Maurice

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tangui Maurice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tangui Maurice. The network helps show where Tangui Maurice may publish in the future.

Co-authorship network of co-authors of Tangui Maurice

This figure shows the co-authorship network connecting the top 25 collaborators of Tangui Maurice. A scholar is included among the top collaborators of Tangui Maurice based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tangui Maurice. Tangui Maurice is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maurice, Tangui. (2025). Prevention of memory impairment and hippocampal injury with blarcamesine in an Alzheimer’s disease model. Neuroscience Letters. 865. 138349–138349.
2.
Crouzier, Lucie, et al.. (2024). Amylovis-201 is a new dual-target ligand, acting as an anti-amyloidogenic compound and a potent agonist of the σ1 chaperone protein. Acta Pharmaceutica Sinica B. 14(10). 4345–4359. 4 indexed citations
3.
Richard, Élodie M., Tangui Maurice, & Benjamin Delprat. (2023). Calcium signaling and genetic rare diseases: An auditory perspective. Cell Calcium. 110. 102702–102702. 2 indexed citations
4.
Canet, Geoffrey, et al.. (2023). The pathomimetic oAβ25–35 model of Alzheimer's disease: Potential for screening of new therapeutic agents. Pharmacology & Therapeutics. 245. 108398–108398. 14 indexed citations
6.
Crouzier, Lucie, Johann Meunier, Martine Schmitt, et al.. (2023). Convolamine, a tropane alkaloid extracted from Convolvulus plauricalis, is a potent sigma‐1 receptor‐positive modulator with cognitive and neuroprotective properties. Phytotherapy Research. 38(2). 694–712. 3 indexed citations
7.
Cresto, Noémie, Marine Blaquière, Pierre Sicard, et al.. (2023). Dual-Hit: Glyphosate exposure at NOAEL level negatively impacts birth and glia-behavioural measures in heterozygous shank3 mutants. Environment International. 180. 108201–108201. 2 indexed citations
8.
Richard, Élodie M., Émilie Brun, Lucie Crouzier, et al.. (2023). Wfs1E864K knock-in mice illuminate the fundamental role of Wfs1 in endocochlear potential production. Cell Death and Disease. 14(6). 387–387. 7 indexed citations
9.
Crouzier, Lucie, Alberto Danese, Yuko Yasui, et al.. (2022). Activation of the sigma-1 receptor chaperone alleviates symptoms of Wolfram syndrome in preclinical models. Science Translational Medicine. 14(631). eabh3763–eabh3763. 48 indexed citations
11.
Forner-Piquer, Isabel, Wendy Klément, Giuseppe Gangarossa, et al.. (2021). Varying modalities of perinatal exposure to a pesticide cocktail elicit neurological adaptations in mice and zebrafish. Environmental Pollution. 278. 116755–116755. 11 indexed citations
12.
Mosier, Philip D., Mauro Niso, Leonardo Brunetti, et al.. (2021). Development of novel phenoxyalkylpiperidines as high-affinity Sigma-1 (σ1) receptor ligands with potent anti-amnesic effect. European Journal of Medicinal Chemistry. 228. 114038–114038. 3 indexed citations
13.
14.
Liévens, Jean-Charles, Shao‐Ming Wang, Jian‐Ying Chuang, et al.. (2020). Sigma-1 receptor chaperones rescue nucleocytoplasmic transport deficit seen in cellular and Drosophila ALS/FTD models. Nature Communications. 11(1). 5580–5580. 36 indexed citations
15.
Scheiner, Matthias, Sandra Gunesch, Matthias Hoffmann, et al.. (2019). Dual-Acting Cholinesterase–Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo. Journal of Medicinal Chemistry. 62(20). 9078–9102. 39 indexed citations
17.
Villard, Vanessa, Julie Espallergues, Emeline Keller, et al.. (2008). Antiamnesic and Neuroprotective Effects of the Aminotetrahydrofuran Derivative ANAVEX1-41 Against Amyloid β25–35-Induced Toxicity in Mice. Neuropsychopharmacology. 34(6). 1552–1566. 95 indexed citations
18.
Pannequin, Julie, Nathalie Delaunay, Charbel Darido, et al.. (2007). Phosphatidylethanol Accumulation Promotes Intestinal Hyperplasia by Inducing ZONAB-Mediated Cell Density Increase in Response to Chronic Ethanol Exposure. Molecular Cancer Research. 5(11). 1147–1157. 34 indexed citations
19.
Espallergues, Julie, Arthur Christopoulos, Vimesh A. Avlani, et al.. (2007). Involvement of the sigma1(σ1) receptor in the anti‐amnesic, but not antidepressant‐like, effects of the aminotetrahydrofuran derivative ANAVEX1‐41. British Journal of Pharmacology. 152(2). 267–279. 26 indexed citations
20.
Maurice, Tangui. (2004). Neurosteroids and σ1Receptors, Biochemical and Behavioral Relevance. Pharmacopsychiatry. 37(S 3). 171–182. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026